Skip to main content

NN announces final settlement with interest groups on unit-linked insurance products

  • Settlement involves approximately EUR 300 million; all legal proceedings to be discontinued
  • Settlement follows earlier measures adopted by NN, including previous compensation rounds of approximately EUR 1 billion
  • Provision of approximately EUR 360 million recognised in the fourth quarter of 2023; with EUR 60 million for hardship cases and customers unaffiliated to the interest groups who have not previously received compensation
  • NN Group has injected EUR 1 billion into NN Life to cover for the provision as well as to improve the use of capital within the group; NN Group is comfortable with a cash capital position between EUR 0.5 and 1.5 billion

NN Group today announces it has agreed on a settlement with interest groups Consumentenclaim,, Woekerpolisproces, Wakkerpolis and Consumentenbond regarding unit-linked insurance products sold in the Netherlands by Nationale-Nederlanden, including Delta Lloyd and ABN AMRO Levensverzekering. The total settlement entails an amount of approximately EUR 300 million.

‘The settlement is an important result for everyone involved in this long-standing industry issue,’ said David Knibbe, CEO of NN Group. ‘We have taken the criticism that certain products did not meet our customers’ expectations seriously, and therefore we are pleased to announce a final settlement with all interest groups. With this settlement we provide clarity to our customers and can finally resolve this issue. We will continue to focus on helping our customers care for what matters most to them.’

The settlement relates to all unit-linked insurance products of customers affiliated with one of the interest groups. All legal proceedings will be discontinued and no new legal proceedings may be initiated by the interest groups and affiliated parties.

Once all details relating to the execution of the settlement are finalised, customers will receive their individual proposal through their respective interest group. The agreement will be final once 90% of these customers agree with their proposal. NN expects this process to take until the end of 2024.

The settlement follows earlier measures taken by NN in the interest of customers for a total amount of approximately EUR 1 billion. These earlier measures were, for example, the Settlement Agreements in 2008.

Financial details

To cover the settlement costs, a provision of approximately EUR 360 million was recognised in the fourth quarter of 2023. This includes EUR 60 million for hardship cases and customers unaffiliated with one of the interest groups who have not previously received compensation. In addition, approximately EUR 20 million is available for these customers through the remainder of a provision recognised as part of the 2008 settlement. These customers can contact NN with questions via +31 (070) 513 91 67 or

At the end of December 2023, NN Group decided to inject EUR 1 billion into its subsidiary NN Life. The injection will cover for the provision whilst the remainder will be deployed according to NN Life’s strategic asset allocation over time. As such, the lower organic capital generation due to the longevity transactions announced on 19 December 2023 can partly be compensated. Following the capital injection, the cash capital position of NN Group at the end of December 2023 was approximately EUR 1 billion, comfortably within the range of between EUR 0.5 and EUR 1.5 billion.

NN Group is comfortable with its capital position following the settlement announced today, the attractive longevity deals and the optimisation of the use of capital within the group. As a result, for 2023 NN Group plans for an increased double digit percentage step-up of the dividend per share versus 2022. From this higher base, management reconfirms its commitment of a progressive dividend per share level, an annual share buyback of at least EUR 250 million and additional excess capital to be returned to shareholders unless used for value-creating opportunities.

At the end of September 2023, the unaudited Solvency II ratios for NN Group and NN Life were approximately 205% and 187%, respectively. The provision for the settlement announced today will have an impact on the Solvency II ratios of NN Group of approximately 3 percentage points and on NN Life of approximately 5 percentage points. For NN Life’s Solvency II ratio, the capital injection will add approximately 19 percentage points.

As indicated in the press release of 19 December 2023, the longevity transactions are expected to increase NN Group’s Solvency II ratio by approximately 8 percentage points and NN Life’s Solvency II ratio by approximately 17 percentage points.

We reiterate that the Solvency II ratios of NN Group and NN Life are sensitive to market movements, for which NN has provided sensitivities in the analyst presentation for the results for the first half of 2023. Market movements since the end of September 2023 are expected to have an adverse impact on the Solvency II ratios of NN Group and NN Life, most notably due to the widening of the mortgage margin. For the Solvency II ratio of NN Group, we expect the negative effects from markets and the settlement to be only partly offset by the longevity transactions. For NN Life, based on preliminary insights based on sensitivities, we expect the Solvency II ratio to land in a range around the unaudited Solvency II ratio as per the end of September 2023.